Block Drug Labeling Exemption Request For BC Analgesic Powder Denied
This article was originally published in The Tan Sheet
Executive Summary
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder was denied by FDA Aug. 28.
You may also be interested in...
Block Exemption Request Differentiates "Label" From "Labeling"
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder complies with provisions of the FD&C Act that differentiate a product's "label" from product "labeling," the company says in a Dec. 22 letter to FDA.
Block Exemption Request Differentiates "Label" From "Labeling"
Block Drug's request for an exemption from the OTC labeling final rule for its BC analgesic powder complies with provisions of the FD&C Act that differentiate a product's "label" from product "labeling," the company says in a Dec. 22 letter to FDA.
Block Drug Small Package Labeling Exemption Denial Mishandled - CHPA
FDA erred in denying Block Drug's request for an exemption from the OTC labeling final rule, the Consumer Healthcare Products Association says in an Oct. 3 letter to the agency.